Search Team

Search by Last Name
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Fish Litigation Blog

Welcome to the Fish & Richardson litigation blog, a community site where our intellectual property, commercial, and white collar litigators share information on nationwide litigation developments and trends. Join the conversation!

Fish Litigation Blog
Filter blogs by
Webinars

Fish Litigation Blog

The depth and breadth of Fish’s litigation practice is constantly expanding to fit the needs of our clients and the realities of the economic, business, and technological challenges they face. Our litigation blog reflects the full expanse of our litigation practice. Among other things, we discuss: developments in patent and trademark litigation, intricacies associated with ITC proceeding, Federal Circuit summaries and Supreme Court decisions, how courts are handling NPE litigation, various manifestations of the America Invents Act (AIA), commercial and business litigation matters, the Delaware Court of Chancery, and white collar defense and government investigation issues.

q&a 2016

Welcome to the conversation!

 


IP Litigation, Life Sciences
December 7, 2016
Survey of the Safe Harbor in the United States and Europe
Authors: Brian D. Coggio, Ron Vogel
IP Litigation, Federal Circuit
December 7, 2016
Federal Circuit Opinion Asetek Danmark a/s v. CMI USA Inc. Cites Patent Damages Treatise
Author: Christopher Marchese
Commercial Litigation
December 1, 2016
False Claims Act: Recent First Circuit Opinion on Remand in U.S. ex rel. Escobar v. United Health Services
Author: Tommy Jacks
IP Litigation, Commercial Litigation
November 30, 2016
Arbitration Risks: Why Arbitration is Not Necessarily Better, Faster, or Cheaper Than Litigation.
Authors: Mike Gaddis, Ph.D., Taj Clayton, Steven H. Stodghill
IP Litigation, Federal Circuit
November 22, 2016
Alert: Federal Circuit Narrows the Types of Patents That Can Be Challenged in a Covered Business Method Review
Author: John A. Dragseth
IP Litigation, Life Sciences
November 18, 2016
Amgen Opposes Apotex’s Petition for Certiorari
Authors: Gina Nellesen, Jenny Shmuel, Ph.D., Tasha M. Francis, Ph.D.
November 17, 2016
Amgen Crystallizes Disagreement in Appeal of Discovery Row
Authors: Gina Nellesen, Jenny Shmuel, Ph.D., Tasha M. Francis, Ph.D.
Commercial Litigation
November 16, 2016
The Corporate Litigant and Rule 30(b)(6) Depositions: The Duty to Prepare the Corporate Representative to Testify
Author: Tommy Jacks
IP Litigation, Life Sciences
November 14, 2016
New Developments in AbbVie’s BPCIA Suit Targeting Amgen’s Humira® Biosimilar
Authors: Tucker N. Terhufen, Jenny Shmuel, Ph.D., Tasha M. Francis, Ph.D.
IP Litigation
November 8, 2016
In re Aqua Products: The Convergence of Administrative and Patent Law
Author: Will Orlady
Commercial Litigation
November 7, 2016
Federal Copyright Preemption of State Law Claims – Still a Powerful Defense Tool in Commercial Litigation
Authors: Mike Gaddis, Ph.D., Tommy Jacks, David S. Morris
load more posts

Stay current with Fish Sign up for our Newsletter